Om

Electra Therapeutics Inc. is a clinical-stage biotechnology company focused on developing precision medicines for immune-mediated diseases and cancer. The company’s programs center on signal regulatory protein, or SIRP, biology, using monoclonal antibodies designed to selectively target disease-driving immune cells while preserving normal immune function. Its lead product candidate, ipsoprubart, is being studied for secondary hemophagocytic lymphohistiocytosis, a severe hyperinflammatory condition, while additional pipeline work includes ELA822 for broader immune and inflammatory indications. Electra Therapeutics operates in the biopharmaceutical sector, where it aims to address serious disorders with limited treatment options through targeted immunology and oncology therapies. Headquartered in South San Francisco, California, the company focuses on current clinical development of novel antibody-based medicines.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ELECTRA THERAPEUTICS MED ENDAVU: Køb Electra Therapeutics ($ETRA) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Electra Therapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.